Application for a clinical RMD research methodology was approved by the EULAR research Committee on the 12th of MARCH 2024, for a total funding of 50’000 Euros.
The EULAR grant for FIARVASC
You may also like
Within FAIRVASC Workpackage 2 (WP2) will capture the legal and ethical environment of each registry, patient perspectives on data sharing and re-use, […]
The FAIRVASC consortium will meet for a Plenary meeting in the Conference Center at the Faculty of Medicine in Kraków, Poland on […]
The FAIRVASC project held its first (kick-off) meeting over 2 days (03rd and 09th June 2020). All partners were represented, and the meeting was […]
1) FAIRVASC has released a new data quality analysis lately. Can you comment on it? Major differences with respect to the previous […]